BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35868640)

  • 21. Forging the links between metabolism and carcinogenesis.
    Guengerich FP
    Mutat Res; 2001 Jul; 488(3):195-209. PubMed ID: 11397649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine.
    Jackson KD; Achour B; Lee J; Geffert RM; Beers JL; Latham BD
    Drug Metab Dispos; 2023 Oct; 51(10):1238-1253. PubMed ID: 37419681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P450 and Other Drug-Metabolizing Enzymes As Therapeutic Targets.
    Foti RS
    Drug Metab Dispos; 2023 Aug; 51(8):936-949. PubMed ID: 37041085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [From the Viewpoint of Drug Metabolism Research].
    Nakajima M
    Yakugaku Zasshi; 2017; 137(6):697-705. PubMed ID: 28566576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Modeling Studies on Cytochrome P450-mediated Drug Metabolism.
    Muthusamy R; Bharatam PV
    Curr Drug Metab; 2021; 22(9):683-697. PubMed ID: 33605853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of sphingolipids in drug metabolism and transport.
    Kim YM; Park TS; Kim SG
    Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):319-31. PubMed ID: 23289866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
    Yamazaki H
    Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harnessing P450 Enzyme for Biotechnology and Synthetic Biology.
    Zhang L; Wang Q
    Chembiochem; 2022 Feb; 23(3):e202100439. PubMed ID: 34542923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).
    Knights KM; Rowland A; Miners JO
    Br J Clin Pharmacol; 2013 Oct; 76(4):587-602. PubMed ID: 23362865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico prediction of cytochrome P450-mediated site of metabolism (SOM).
    Liu X; Shen Q; Li J; Li S; Luo C; Zhu W; Luo X; Zheng M; Jiang H
    Protein Pept Lett; 2013 Mar; 20(3):279-89. PubMed ID: 22591483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research progress of zebrafish used in drug metabolism].
    Chen QX; Zeng S
    Yao Xue Xue Bao; 2011 Sep; 46(9):1026-31. PubMed ID: 22121770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes.
    Uno Y; Uehara S; Yamazaki H
    Biochem Pharmacol; 2016 Dec; 121():1-7. PubMed ID: 27318253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochrome P450: what have we learned and what are the future issues?
    Guengerich FP
    Drug Metab Rev; 2004 May; 36(2):159-97. PubMed ID: 15237850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P450s and other enzymes in drug metabolism and toxicity.
    Guengerich FP
    AAPS J; 2006 Mar; 8(1):E101-11. PubMed ID: 16584116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P450 and the biological clock in mammals.
    Froy O
    Curr Drug Metab; 2009 Feb; 10(2):104-15. PubMed ID: 19275546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Robust Quantitative Structure-Activity Relationship Models for CYP2C9, CYP2D6, and CYP3A4 Catalysis and Inhibition.
    Gonzalez E; Jain S; Shah P; Torimoto-Katori N; Zakharov A; Nguyễn ÐT; Sakamuru S; Huang R; Xia M; Obach RS; Hop CECA; Simeonov A; Xu X
    Drug Metab Dispos; 2021 Sep; 49(9):822-832. PubMed ID: 34183376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes.
    Lapham K; Callegari E; Cianfrogna J; Lin J; Niosi M; Orozco CC; Sharma R; Goosen TC
    Drug Metab Dispos; 2020 Dec; 48(12):1350-1363. PubMed ID: 33020067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
    Johansson I; Ingelman-Sundberg M
    Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial Intelligence in Drug Safety and Metabolism.
    Smith GF
    Methods Mol Biol; 2022; 2390():483-501. PubMed ID: 34731484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism.
    Tracy TS; Chaudhry AS; Prasad B; Thummel KE; Schuetz EG; Zhong XB; Tien YC; Jeong H; Pan X; Shireman LM; Tay-Sontheimer J; Lin YS
    Drug Metab Dispos; 2016 Mar; 44(3):343-51. PubMed ID: 26681736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.